Skip to content
MedsAcross

Medicine

Vancomycin 250 mg/5 mL powder for oral solution

Vancomycin · Oral
Available on requestPrescription onlyUS FDA Cold chainGeneric name

Vancomycin 250 mg/5 mL powder for oral solution is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store at refrigerated conditions, 2° to 8°C (36° to 46°F). After mixing…

Key facts

Active ingredient (INN)
Vancomycin
Brand
Sold under the generic name
Strength
250 mg/5 mL
Dosage form
Powder for oral solution
Route
Oral
Packs
300 mL, 150 mL, 80 mL and 8 more
Manufacturers
Bryant Ranch PrepackANI Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at refrigerated conditions, 2° to 8°C (36° to 46°F). After mixing, refrigerate and use within two weeks.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A07AA09 Vancomycin
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
9 September 2019
Identifiers
RxCUI 2000134DailyMed set ID 8193f588-a032-451e-a0a1-819a5ea834c8, 9b6a7a21-4fde-40c6-a420-a8546a4dc701, 28fe3c01-cf87-41c0-87fd-f93a40524335 +4NDC 71335-2948, 63629-1971, 72162-1775 +4Application ANDA061667

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
300 mL in 1 bottle, plastic62559-830-03ANI Pharmaceuticals9 September 2019
150 mL in 1 bottle, plastic62559-830-55ANI Pharmaceuticals9 September 2019
80 mL in 1 bottle, plastic62559-830-80ANI Pharmaceuticals9 September 2019
80 mL in 1 bottle63629-1970-1Bryant Ranch Prepack9 September 2019
150 mL in 1 bottle63629-1971-1Bryant Ranch Prepack9 September 2019
300 mL in 1 bottle63629-1972-1Bryant Ranch Prepack9 September 2019
80 mL in 1 bottle71335-2948-1Bryant Ranch Prepack6 November 2025
150 mL in 1 bottle71335-2950-1Bryant Ranch Prepack5 November 2025
150 mL in 1 bottle, plastic72162-1775-2Bryant Ranch Prepack27 September 2023
300 mL in 1 bottle, plastic72162-1775-4Bryant Ranch Prepack27 September 2023
80 mL in 1 bottle, plastic72162-1775-7Bryant Ranch Prepack27 September 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 15 April 1986Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Vancomycin

Clinical summary

Vancomycin is a glycopeptide antibacterial indicated for the treatment of Clostridioides difficile -associated diarrhea, among other approved uses. It is available as powder for injection, injection and capsules for intravenous, oral and intravitreal use. MedsAcross supplies Vancomycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Vancomycin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Vancomycin 250 mg/5 mL powder for oral solution for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.